中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2013年
19期
26-27
,共2页
张斌%王鲁梅%侯志勇%李仲均%王静文
張斌%王魯梅%侯誌勇%李仲均%王靜文
장빈%왕로매%후지용%리중균%왕정문
局部晚期宫颈癌%紫杉醇%卡铂化疗
跼部晚期宮頸癌%紫杉醇%卡鉑化療
국부만기궁경암%자삼순%잡박화료
Locally advanced cervical cancer%Paclitaxel%Carboplatin
目的:观察局部晚期宫颈癌新辅助化疗的临床治疗效果。方法:选取笔者所在医院2010-2012年收治的局部晚期宫颈癌患者20例,其中Ⅰb2期的患者6例,Ⅱa 期的患者12例,Ⅱb 期患者2例。通过2个疗程的紫衫醇联合卡铂化疗方案静脉化疗之后,对所有患者都进行宫颈癌根治术,观察分析其治疗效果。结果:化疗的总有效率为70.0%(14/20);Ⅰb2期的总有效率为66.7%(4/6),Ⅱa 期的总有效率为66.7%(8/12),Ⅱb 期的总有效率为50.0%(1/2),三组间比较差异无统计学意义(P>0.05)。鳞癌的有效率为66.7%(8/12),腺鳞癌的有效率为25.0%(1/4),腺癌的有效率为50.0%(2/4),鳞癌和腺鳞癌的疗效比较差异有统计学意义(P<0.05)。结论:紫杉醇联合卡铂化疗,对于局部晚期宫颈癌的治疗有显著的效果,且有很好的耐受性,值得临床推广。
目的:觀察跼部晚期宮頸癌新輔助化療的臨床治療效果。方法:選取筆者所在醫院2010-2012年收治的跼部晚期宮頸癌患者20例,其中Ⅰb2期的患者6例,Ⅱa 期的患者12例,Ⅱb 期患者2例。通過2箇療程的紫衫醇聯閤卡鉑化療方案靜脈化療之後,對所有患者都進行宮頸癌根治術,觀察分析其治療效果。結果:化療的總有效率為70.0%(14/20);Ⅰb2期的總有效率為66.7%(4/6),Ⅱa 期的總有效率為66.7%(8/12),Ⅱb 期的總有效率為50.0%(1/2),三組間比較差異無統計學意義(P>0.05)。鱗癌的有效率為66.7%(8/12),腺鱗癌的有效率為25.0%(1/4),腺癌的有效率為50.0%(2/4),鱗癌和腺鱗癌的療效比較差異有統計學意義(P<0.05)。結論:紫杉醇聯閤卡鉑化療,對于跼部晚期宮頸癌的治療有顯著的效果,且有很好的耐受性,值得臨床推廣。
목적:관찰국부만기궁경암신보조화료적림상치료효과。방법:선취필자소재의원2010-2012년수치적국부만기궁경암환자20례,기중Ⅰb2기적환자6례,Ⅱa 기적환자12례,Ⅱb 기환자2례。통과2개료정적자삼순연합잡박화료방안정맥화료지후,대소유환자도진행궁경암근치술,관찰분석기치료효과。결과:화료적총유효솔위70.0%(14/20);Ⅰb2기적총유효솔위66.7%(4/6),Ⅱa 기적총유효솔위66.7%(8/12),Ⅱb 기적총유효솔위50.0%(1/2),삼조간비교차이무통계학의의(P>0.05)。린암적유효솔위66.7%(8/12),선린암적유효솔위25.0%(1/4),선암적유효솔위50.0%(2/4),린암화선린암적료효비교차이유통계학의의(P<0.05)。결론:자삼순연합잡박화료,대우국부만기궁경암적치료유현저적효과,차유흔호적내수성,치득림상추엄。
Objective:To observe the clinical effects of new adjuvant chemotherapy on locally advanced carcinoma of the cervix.Methods:Select the author’s hospital in 2010-2012 treated 20 patients with locally advanced cervical cancer,including Ⅰb2 period 6 cases,Ⅱa period 12 cases,Ⅱb period 2 cases. Through two course of purple shirts alcohol plus carboplatin chemotherapy regimens after intravenous chemotherapy,for all patients with cervical cancer radical,observation analysis of the therapeutic effect.Results:Chemotherapy,the total effective rate was 70.0%(14/20);Ⅰb2 phase of the total effective rate was 66.7%(4/6),Ⅱa period of the total effective rate was 66.7%(8/12),Ⅱb of the total effective rate was 50.0%(1/2),the difference among three groups had no statistical significance(P>0.05). Squamous cell carcinomas of the effective rate was 66.7%(8/12),effective rate was 25.0%(1/4) of gland scale cancer,gland cancer the effective rate was 50.0%(2/4),squamous carcinoma and the curative effect of gland scale cancer comparative difference was statistically significant(P<0.05). Conclusion:paclitaxel plus carboplatin chemotherapy for locally advanced cervical cancer treatment has a significant effect,and have very good tolerance,worth clinical promotion.